» Articles » PMID: 26162600

Evaluation of Potential Drug- Herb Interactions Among a Group of Palestinian Patients with Chronic Diseases

Overview
Publisher Biomed Central
Date 2015 Jul 12
PMID 26162600
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study was to find the prevalence of potential drug-herb interactions in patients with chronic diseases and identify factors associated with these interactions if present.

Method: The study was a questionnaire based cross-sectional study. It was conducted at a number of governmental primary healthcare centers which include outpatient clinics for chronic diseases between July and November 2013. Patients come to these clinics monthly or bimonthly to receive their medications for their chronic diseases free. The patients in this study were seen at these clinics and their medications were reported from the most recent prescription in their files.

Results: A total of 400 patients agreed to be interviewed, 209 (52.3%) were females. The most commonly used medications were metformin, insulin, and enalapril. Among the patients, 237 (59.3%) were using 395 medicinal herbs. The most commonly used herbs were sage, anise and peppermint. In 51 out of the 237 cases (21.5%) at least one potential drug-herb interaction was found. Male patients were more likely to have potential drug-herb interactions. Patients with potential drug herb interactions were older, having a higher mean number of chronic diseases and medications (P-value < 0.05). Only 133 out of 237 (56.1%) users told their prescribers or pharmacists before using medicinal herbs.

Conclusion: Use of medicinal herbs is a common practice among Palestinian patients attending primary healthcare centers. A substantial proportion failed to disclose to their doctors or pharmacists about herbal products they used, therefore, the physicians and pharmacists are recommended to ask patients about the use of medicinal herbs to avoid any possible negative outcomes. Better counseling and communication between patients and healthcare providers is recommended.

Citing Articles

Real-world Evidence of the Herb-drug Interactions.

Pan H, Wu L, Wang P, Chiu P, Wang M J Food Drug Anal. 2024; 30(3):316-330.

PMID: 39666292 PMC: 9635910. DOI: 10.38212/2224-6614.3428.


Beliefs, awareness, use, and factors associated with herbal supplements usage among patients with chronic diseases-A cross-sectional insight from Alkharj, Saudi Arabia.

Albassam A, Alenzi A, Alhaqbani N, Alhouty F, Almalki Z, Alshehri A PLoS One. 2024; 19(1):e0295116.

PMID: 38232068 PMC: 10793931. DOI: 10.1371/journal.pone.0295116.


Safety Concerns Related to the Simultaneous Use of Prescription or Over-the-Counter Medications and Herbal Medicinal Products: Survey Results among Latvian Citizens.

Sile I, Teterovska R, Onzevs O, Ardava E Int J Environ Res Public Health. 2023; 20(16).

PMID: 37623137 PMC: 10454617. DOI: 10.3390/ijerph20166551.


Inhibitory effect of hieron on human cytochrome P450.

Lin F, Lin X, Wang X, Mei G, Chen B, Yao H Front Pharmacol. 2023; 14:1108867.

PMID: 36874034 PMC: 9975586. DOI: 10.3389/fphar.2023.1108867.


A comprehensive evaluation of potentially significant drug-drug, drug-herb, and drug-food interactions among cancer patients receiving anticancer drugs.

Koni A, Nazzal M, Suwan B, Sobuh S, Abuhazeem N, Salman A BMC Cancer. 2022; 22(1):547.

PMID: 35568834 PMC: 9107751. DOI: 10.1186/s12885-022-09649-3.


References
1.
Tachjian A, Maria V, Jahangir A . Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol. 2010; 55(6):515-25. PMC: 2831618. DOI: 10.1016/j.jacc.2009.07.074. View

2.
Hassan Y, Al-Ramahi R, Aziz N, Ghazali R . Adverse drug events in hospitalized patients with chronic kidney disease. Int J Clin Pharmacol Ther. 2010; 48(9):571-6. DOI: 10.5414/cpp48571. View

3.
Ali-Shtayeh M, Jamous R, Jamous R . Complementary and alternative medicine use amongst Palestinian diabetic patients. Complement Ther Clin Pract. 2011; 18(1):16-21. DOI: 10.1016/j.ctcp.2011.09.001. View

4.
Goldstein L, Elias M, Ron-Avraham G, Biniaurishvili B, Madjar M, Kamargash I . Consumption of herbal remedies and dietary supplements amongst patients hospitalized in medical wards. Br J Clin Pharmacol. 2007; 64(3):373-80. PMC: 2000642. DOI: 10.1111/j.1365-2125.2007.02878.x. View

5.
Peng C, Glassman P, Trilli L, Hayes-Hunter J, Good C . Incidence and severity of potential drug-dietary supplement interactions in primary care patients: an exploratory study of 2 outpatient practices. Arch Intern Med. 2004; 164(6):630-6. DOI: 10.1001/archinte.164.6.630. View